NVO
Novo Nordisk A/S · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom -2.0% ·
netto nieuwe posities -6.2%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 347.39K | $13.21M | n/a | −1 |
| Q2 2026 | 132 | 0 | 235.88M | $11.31B | +12 | −13 |
| Q1 2026 | 134 | -8 | 242.80M | $8.91B | +5 | −13 |
| Q4 2025 | 140 | +1 | 228.46M | $11.63B | +3 | −2 |
| Q3 2025 | 19 | -1 | 80.89M | $4.49B | +2 | −3 |
| Q2 2025 | 17 | -1 | 53.30M | $3.68B | +1 | −2 |
| Q1 2025 | 16 | 0 | 43.10M | $3.00B | n/a | n/a |
| Q4 2024 | 16 | -1 | 48.20M | $4.15B | +1 | −2 |
| Q3 2024 | 16 | -1 | 43.13M | $5.09B | +1 | −2 |
| Q2 2024 | 17 | n/a | 46.04M | $6.57B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management ✦ | 12.64M | -5.0% | $1.09B | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 8.31M | +1.5% | $715.08M | 1.1% | ▲ Add | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 6.35M | -33.8% | $545.81M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passief) | 6.06M | n/a | $520.92M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Capital World Investors ✦ | 4.45M | -0.2% | $382.38M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | Markel Group ✦ | 2.15M | 0.0% | $184.94M | 1.6% | Held | 3 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 2.05M | +126.9% | $176.77M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 1.84M | Nieuw | $158.66M | 0.4% | New | 1 | SEC ↗ |
| 9 | Tiger Global Management ✦ | 1.27M | 0.0% | $109.16M | 0.4% | Held | 3 | SEC ↗ |
| 10 | Marshall Wace ✦ | 1.17M | +544.0% | $100.43M | 0.1% | ▲ Add | 3 | SEC ↗ ×4 |
| 11 | Wellington Management ✦ | 830.43K | +135.3% | $71.43M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 12 | Citadel Advisors ✦ | 631.06K | +53.3% | $54.28M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Millennium Management ✦ | 355.21K | -49.9% | $30.56M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 51.34K | +0.7% | $4.42M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 15 | Arrowstreet Capital ✦ | 48.48K | -89.2% | $4.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 53 | 0.0% | $4,559 | 0.0% | Held | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Two Sigma Investments | $158.66M | 0.4% |
Verlaten
| Adage Capital Partners | $94.56M | was 0.2% |
| Coatue Management | $38.86M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 1.21M aandelen, $43.09M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.